141 related articles for article (PubMed ID: 9126232)
1. Age-specific reference ranges for serum prostate-specific antigen.
Richardson TD; Oesterling JE
Urol Clin North Am; 1997 May; 24(2):339-51. PubMed ID: 9126232
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
3. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.
Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H
J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605
[TBL] [Abstract][Full Text] [Related]
4. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.
Partin AW; Criley SR; Subong EN; Zincke H; Walsh PC; Oesterling JE
J Urol; 1996 Apr; 155(4):1336-9. PubMed ID: 8632568
[TBL] [Abstract][Full Text] [Related]
5. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
[TBL] [Abstract][Full Text] [Related]
6. Age specific prostate specific antigen reference ranges: population specific.
Borer JG; Sherman J; Solomon MC; Plawker MW; Macchia RJ
J Urol; 1998 Feb; 159(2):444-8. PubMed ID: 9649260
[TBL] [Abstract][Full Text] [Related]
7. Influence of patient age on the serum PSA concentration. An important clinical observation.
Oesterling JE; Cooner WH; Jacobsen SJ; Guess HA; Lieber MM
Urol Clin North Am; 1993 Nov; 20(4):671-80. PubMed ID: 7505975
[TBL] [Abstract][Full Text] [Related]
8. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges.
Meshref AW; Bazinet M; Trudel C; Aronson S; Peloquin F; Nachabe M; Dessureault J; Aprikian AG; Begin LR; Elhilali MM
Urology; 1995 Jun; 45(6):972-9. PubMed ID: 7539562
[TBL] [Abstract][Full Text] [Related]
9. Age-specific reference ranges for PSA in the detection of prostate cancer.
DeAntoni EP
Oncology (Williston Park); 1997 Apr; 11(4):475-82, 485; discussion 485-6, 489. PubMed ID: 9130271
[TBL] [Abstract][Full Text] [Related]
10. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
[TBL] [Abstract][Full Text] [Related]
11. Potential effects of age-specific reference ranges for serum prostate-specific antigen.
Lankford SP; Peters KL; Elser RC
Eur Urol; 1995; 27(3):182-6. PubMed ID: 7541357
[TBL] [Abstract][Full Text] [Related]
12. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.
Oesterling JE; Jacobsen SJ; Cooner WH
J Urol; 1995 Apr; 153(4):1160-3. PubMed ID: 7532725
[TBL] [Abstract][Full Text] [Related]
13. The clinical usefulness of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese.
Wu TT; Huang JK
Urol Int; 2004; 72(3):208-11. PubMed ID: 15084763
[TBL] [Abstract][Full Text] [Related]
14. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
[TBL] [Abstract][Full Text] [Related]
15. [Detection of prostate cancer in urological practice: clinical establishment of serum PSA reference values by age].
Yamazaki H; Suzuki Y; Madarame A; Katoh N; Masuda F; Ohishi ; Endo K
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):702-9. PubMed ID: 8709448
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
17. Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer.
Vashi AR; Oesterling JE
Mayo Clin Proc; 1997 Apr; 72(4):337-44. PubMed ID: 9121181
[TBL] [Abstract][Full Text] [Related]
18. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
Carter HB; Epstein JI; Chan DW; Fozard JL; Pearson JD
JAMA; 1997 May; 277(18):1456-60. PubMed ID: 9145718
[TBL] [Abstract][Full Text] [Related]
19. Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients.
Battikhi MN
Prostate Cancer Prostatic Dis; 2003; 6(3):256-60. PubMed ID: 12970732
[TBL] [Abstract][Full Text] [Related]
20. Values for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population.
Mungan AG; Erol B; Akduman B; Bozdogan G; Kiran S; Yesilli C; Mungan NA
Clin Chem Lab Med; 2007; 45(7):912-6. PubMed ID: 17617037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
